The Medical Device Recall Improvement Act of 2025 aims to enhance the transparency and efficiency of medical device recalls by establishing a new electronic notification system. It directs the Secretary of Health and Human Services to develop an electronic format for recall notifications, which manufacturers and importers must use to submit detailed information to the FDA. This electronic format will include crucial data elements such as the specific reason for the recall, the unique device identifier, and comprehensive information tailored for both healthcare professionals and patients regarding risks and necessary actions. Following FDA review, manufacturers are required to electronically notify device user facilities and health professionals, and the Secretary must maintain a publicly accessible electronic database of these notifications. A significant provision requires recall strategies to include direct patient notification for specific high-risk devices, such as those that are implanted, life-sustaining, or used in pediatric populations, ensuring patients receive critical safety information. Failure to comply with these new electronic notification and patient notice requirements will be considered a prohibited act under the Federal Food, Drug, and Cosmetic Act, strengthening enforcement and accountability.